Repurposing Itraconazole as a Treatment for Advanced Prostate Cancer: A Noncomparative Randomized Phase II Trial in Men With Metastatic Castration-Resistant Prostate Cancer

BACKGROUND. The antifungal drug itraconazole inhibits angiogenesis and Hedgehog signaling and delays tumor growth in murine prostate cancer xenograft models. We conducted a noncomparative, randomized, phase II study evaluating the antitumor efficacy of two doses of oral itraconazole in men with meta...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Antonarakis, Emmanuel S., Heath, Elisabeth I., Smith, David C., Rathkopf, Dana, Blackford, Amanda L., Danila, Daniel C., King, Serina, Frost, Anja, Ajiboye, A. Seun, Zhao, Ming, Mendonca, Janet, Kachhap, Sushant K., Rudek, Michelle A., Carducci, Michael A.
Format: Artigo
Jezik:Inglês
Izdano: AlphaMed Press 2013
Teme:
Genitourinary Cancer: Prostate
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3579600/
https://ncbi.nlm.nih.gov/pubmed/23340005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-314
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items